Research Triangle Park, NC — (Marketwired) – June 8, 2016– Fennec Pharmaceuticals Inc. (TSX: FRX, OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated May 9, 2016 (the “Circular”) for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Boston, Massachusetts on June 8, 2016 (the “Meeting”). Detailed results of the vote for the election of directors are set out below:
Name of Nominee |
Votes For |
% Votes For |
Votes Withheld |
% Votes Withheld |
| Dr. Khalid Islam | 5,960,408 | 99.95% | 2,856 | 0.05% |
| Mr. Adrian Haigh | 5,960,335 | 99.95% | 2,929 | 0.05% |
| Mr. Chris A. Rallis | 5,960,335 | 99.95% | 2,929 | 0.05% |
| Mr. Rostislav Raykov | 5,960,335 | 99.95% | 2,929 | 0.05% |
For further information, please contact:
Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144